Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heav...
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
About this item
Full title
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
Author / Creator
Thompson, P A , Prince, H M , Seymour, J F , Ritchie, D , Stokes, K , Burbury, K , Wolf, M , Peinert, S , Joyce, T and Harrison, S J
Publisher
London: Nature Publishing Group UK
Journal title
Bone marrow transplantation (Basingstoke), 2011-05, Vol.46 (5), p.764-765
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_874183202
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_874183202
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2010.180
